Acromegaly

• CLINICAL_TRIALS trial_result · 2008-04-01
  Clinical Trial Update: Acute Application of Pegvisomant and Octreotide in Acromegaly [Phase 4]

  A Phase 4 clinical trial update examining the acute use of pegvisomant and octreotide in patients with acromegaly.

• CLINICAL_TRIALS trial_result · 2008-03-25
  Clinical Trial Update: Change in Quality of Life After Addition of Weekly 40 mg Pegvisomant/Placebo in Controlled Acromegalic Patients [Phase 4]

  This Phase 4 clinical trial update reports changes in quality of life after addition of weekly 40 mg pegvisomant versus placebo in controlle…

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: Sandostatin LAR Depot vs. Surgery for Treating Acromegaly [Phase 2]

  A Phase 2 trial comparing Sandostatin LAR Depot to surgery for acromegaly has completed.

• CLINICAL_TRIALS trial_result · 2008-03-03
  Clinical Trial Update: Lanreotide Autogel-120 mg as First-Line Treatment of Acromegaly [Phase 4]

  Phase 4 clinical trial update indicates Lanreotide Autogel 120 mg was studied as first-line therapy for acromegaly; the trial status is comp…

• CLINICAL_TRIALS trial_result · 2008-02-15
  Clinical Trial Update: Prediction of Tumor Shrinkage in Acromegaly

  This clinical trial update reports on a completed study evaluating predictors of tumor shrinkage in acromegaly.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2008-02-14
  Clinical Trial Update: Cardiovascular Outcome After Surgery or Somatostatin Analogues

  This clinical trial update reports cardiovascular outcomes in acromegaly patients treated with surgery versus somatostatin analogue therapy,…

• CLINICAL_TRIALS trial_result · 2007-04-17
  Clinical Trial Update: Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly [Phase 4]

  Phase 4 trial update evaluating dose escalation of Octreotide-LAR as first-line therapy in resistant acromegaly; the study is reported as co…

• CLINICAL_TRIALS trial_result · 2006-09-08
  Clinical Trial Update: Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction [Phase 4]

  Phase 4 trial comparing lanreotide Autogel and octreotide LAR in acromegaly found comparable effects on GH and IGF-I levels and patient sati…